We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.08%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$42.8B
AUM Growth
+$3.35B
(+8.5%)
Cap. Flow
+$1.35B
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
14.82%
Holding
2,894
New
39
Increased
2,631
Reduced
168
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$21.8M |
| 2 |
Chevron
CVX
|
+$20.5M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$19.7M |
| 4 |
Incyte
INCY
|
+$17.8M |
| 5 |
ExxonMobil
XOM
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SE
Spectra Energy Corp Wi
SE
|
+$49.6M |
| 2 |
STJ
St Jude Medical
STJ
|
+$41.1M |
| 3 |
LLTC
Linear Technology Corp
LLTC
|
+$30.3M |
| 4 |
HAR
Harman International Industries
HAR
|
+$13.8M |
| 5 |
ENH
Endurance Specialty Holdings Ltd
ENH
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.2% |
| 2 | Technology | 15.06% |
| 3 | Healthcare | 13.05% |
| 4 | Industrials | 10.88% |
| 5 | Consumer Discretionary | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CY
751
DELISTED
Cypress Semiconductor
CY
| $8M | 0.02% |
581,634
+32,717
| +6% | +$418K |
|
752
Flowers Foods
FLO
$1.51B
| $7.99M | 0.02% |
411,626
+3,834
| +0.9% | +$75.3K |
|
|
CONE
753
DELISTED
CyrusOne Inc Common Stock
CONE
| $7.98M | 0.02% |
155,045
+68,362
| +79% | +$3.36M |
|
754
Chemed
CHE
$7.1B
| $7.97M | 0.02% |
43,623
+7,306
| +20% | +$1.27M |
|
755
Cirrus Logic
CRUS
$6.65B
| $7.97M | 0.02% |
131,252
+4,546
| +4% | +$259K |
|
|
NUVA
756
DELISTED
NuVasive, Inc.
NUVA
| $7.91M | 0.02% |
105,923
+4,894
| +5% | +$355K |
|
757
Sensient Technologies
SXT
$5.28B
| $7.9M | 0.02% |
99,689
+3,673
| +4% | +$289K |
|
758
Owens Corning
OC
$11.2B
| $7.9M | 0.02% |
128,733
+7,463
| +6% | +$428K |
|
759
Tanger
SKT
$4.71B
| $7.89M | 0.02% |
240,658
+15,266
| +7% | +$517K |
|
760
Burlington
BURL
$23.4B
| $7.88M | 0.02% |
80,997
+4,159
| +5% | +$368K |
|
761
Voya Financial
VOYA
$9.09B
| $7.87M | 0.02% |
207,221
+13,254
| +7% | +$534K |
|
762
Louisiana-Pacific
LPX
$5.02B
| $7.86M | 0.02% |
316,480
+13,224
| +4% | +$292K |
|
|
LHO
763
DELISTED
LaSalle Hotel Properties
LHO
| $7.82M | 0.02% |
269,972
+11,090
| +4% | +$329K |
|
764
Trinity Industries
TRN
$2.73B
| $7.78M | 0.02% |
407,037
+13,271
| +3% | +$261K |
|
765
Ralph Lauren
RL
$23B
| $7.76M | 0.02% |
95,123
-12,373
| -12% | -$1.02M |
|
766
CoStar Group
CSGP
$12B
| $7.76M | 0.02% |
374,520
+15,890
| +4% | +$323K |
|
767
Hawaiian Electric Industries
HE
$2.28B
| $7.74M | 0.02% |
232,238
+45,276
| +24% | +$1.5M |
|
|
SKX
768
DELISTED
Skechers
SKX
| $7.72M | 0.02% |
281,382
+7,013
| +3% | +$182K |
|
769
UMB Financial
UMBF
$11.1B
| $7.63M | 0.02% |
101,329
+3,320
| +3% | +$254K |
|
770
First Industrial Realty Trust
FR
$8.75B
| $7.63M | 0.02% |
286,492
+14,609
| +5% | +$391K |
|
771
Monolithic Power Systems
MPWR
$64.7B
| $7.62M | 0.02% |
82,715
+2,494
| +3% | +$221K |
|
|
PRXL
772
DELISTED
Parexel International Corp
PRXL
| $7.61M | 0.02% |
120,557
+1,880
| +2% | +$124K |
|
773
Live Nation Entertainment
LYV
$42.7B
| $7.6M | 0.02% |
250,143
+9,410
| +4% | +$269K |
|
774
AGCO
AGCO
$7.76B
| $7.59M | 0.02% |
126,137
+4,518
| +4% | +$278K |
|
775
TD Synnex
SNX
$20.2B
| $7.57M | 0.02% |
135,194
+4,490
| +3% | +$267K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2017 Portfolio in Review
As of Q1 2017, RhumbLine Advisers held 2,894 positions worth $42.8B, up 8.5% from $39.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RhumbLine Advisers deployed $1.35B of net new capital in Q1 2017, opening 39 new positions and adding to 2,631 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Biogen, an estimated $8.21M trimmed.
- RhumbLine Advisers's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
- RhumbLine Advisers added most to Abbott in Q1 2017, an estimated $21.8M increase.
- RhumbLine Advisers's biggest Q1 2017 reduction was Biogen, cutting an estimated $8.21M.
- RhumbLine Advisers fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $49.6M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $42.8B portfolio in Q1 2017.
- RhumbLine Advisers opened 39 new positions and closed 44 in Q1 2017.
- RhumbLine Advisers's portfolio value rose 8.5% quarter-over-quarter to $42.8B.
Based on RhumbLine Advisers's 13F filing for Q1 2017, filed 2 May 2017.